Skip to content

The blood circulation during end-of-life. Observation of the blood circulation of hospice patients before and after the diagnosis of dying: a pilot study.

The blood circulation during end-of-life. Observation of the blood circulation of hospice patients before and after the diagnosis of dying: a pilot study. - The blood circulation during end-of-life.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36876
Enrollment
25
Registered
2012-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patiënten gedurende de laatste fase van het leven Patients during end-of-life

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Estimated life expectancy of three months or less 2. Age >= 18 years

Exclusion criteria

Exclusion criteria: 1. Insufficient understanding of the Dutch language 2. Functional disorders (for example severe dementia or delirium) 3. Great oral cavity defect as a result of a (treatment of) malignancy

Design outcomes

Primary

MeasureTime frame
1.The feasibility of the pilot (to determine if the study could be done on larger scale), determined on three criteria: a. possible practical problems of measuring, b. the willingness to participate the study, c. reactions to the measurements of patients and their relatives. 2.An inventory of the course of the blood circulation, measured by four non-invasive measurement instruments, before and after the recognition of the dying phase.

Secondary

MeasureTime frame
The relationship of the course of the blood circulation (the pulsatory volume, the heart rate, blood pressure, cardiac output, systemic vascular resistance, peripheral perfusion, peripheral oxygenation and perfusion of the microcirculation) measured through four non-invasive measurement instruments with clinical signs of the approached death to patients with a life expectancy of only days.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)